At a glance
ClinicalIndex Comparison RecordN/ACompleted· 742 enrolled
Drug / intervention
DIABE-TEXTdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Supporting People With Type 2 Diabetes in Effective Use of Their Medicine Through a System Comprising Mobile Health Technology Integrated With Clinical Care
Fundació d'investigació Sanitària de les Illes Balears·interventional·Posted Aug 16, 2021·Updated Feb 28, 2025
In Brief
A clinical study evaluating DIABE-TEXT for Diabetes Mellitus, Type 2. Completed, enrolled 742 participants across 1 site.
Detailed Summary
This study aims at evaluating the effectiveness of an intervention based on the use of a mobile-device based system delivering automated, tailored brief text messages to offer support for medicine use and lifestyle recommendations alongside usual care to people with type 2 diabetes.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes Mellitus, Type 2
CountriesSpain
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
First PostedAug 2021
Enrollment StartOct 2021
Primary CompletionMar 2023
Study CompletionApr 2023
TodayJul 2026
First PostedAug 16, 2021
Enrollment StartOct 6, 2021
Primary CompletionMar 31, 2023
Study CompletionApr 30, 2023
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 4.9 years ago
Interventions
DIABE-TEXTdevice
Participants will receive 170 text messages in their mobile phones during twelve months.